Peter Libby: Inflammation and Traditional Risk Factors Work Together in Cardiovascular Disease
Peter Libby, Mallinckrodt Professor of Medicine and Cardiovascular Specialist at Harvard Medical School and Brigham and Women’s Hospital, reposted from International Atherosclerosis Society on LinkedIn:
”Informative new vignettes about Inflammation and Cardiovascular Disease. Inflammation and traditional risk factors work together!
The title echoes a paper I did a few years ago: Strandberg TE, Libby P, Kovanen PT. A tale of two therapies lipid-lowering vs. anti-inflammatory therapy: a false dichotomy? Cardiovasc Pharmacol 2021;7(3):238-241. ”
Qutoing International Atherosclerosis Society‘s post:
”It’s Inflammation Monday!
Every Monday, IAS will be highlighting the recordings of the live lectures from the Inflammation Academy, held in Madrid on August 28, 2025.
For the first lecture highlight, hear from Peter Libby, MD, as he speaks on how inflammatory mechanisms link traditional risk factors to adverse cardiovascular events.
Watch to learn more.”
Stay updated with Hemostasis Today.
-
Dec 6, 2025, 18:02ASH25 Day 1: Don’t Miss The Highlights
-
Dec 6, 2025, 15:44Atul Gupta on Where The Healthcare Innovation is Headed
-
Dec 6, 2025, 15:22Nathan White on How Inflammation Contributes to Coagulopathy After Trauma
-
Dec 6, 2025, 15:02Anas Younes on AstraZeneca’s Aims in Blood Cancer to Be Presented at ASH25
-
Dec 6, 2025, 14:08David Alderman: ASH25 is Live
-
Dec 6, 2025, 13:53Isabelle Mahé Presents The Proposals from INNOVTE CAT Working Group
-
Dec 6, 2025, 11:50Steve Tuplin on Roche’s Mission at ASH25
-
Dec 6, 2025, 11:13Khaled Musallam on The Lancet Haematology Podcast: Your ASH25 Roadmap
-
Dec 5, 2025, 03:46Sreeni Sivan Pillai: Preventing Thrombophlebitis and Upper Limb DVT in PICC Lines